ILVO validation has been successfully completed for aflatoxin M1. A great achievement for us since the final remarks of the validation are that both methods have higher accuracy than the confirmatory method (HPLC).
Prognosis Biotech started 7 years ago as the smallest newcomer in the market of food safety products. In a market where the competition is highly sophisticated and within a continuous improving environment, Prognosis Biotech in this short period of time achieved to possess an important role in the food diagnostics industry.
Everybody in ProGnosis Biotech have been excelling themselves every day in order to cope and outperform the competition. The external validation of ILVO for Elisa and Lateral Flow products for aflatoxin m1 is a milestone for our company. This achievement makes us very proud, especially when ILVO confirms that our Symmetric M1 and Bio-Shield M1 ES products have higher accuracy compared with the confirmatory method (HPLC).
ProGnosis Biotech will continue to follow its innovative and people-oriented approach in the forthcoming years. Finally, we would like to express our sincere gratitude to Wim Reybroeck and Eline De Wispelaere for their valuable cooperation during this project.
More information about ILVO